Physician

Daniel C Terveen, M.D.

According to 2025 Medicare claims, Daniel Terveen, M.D. (NPI: 1053791715) practices ophthalmology in the Sioux Falls, SD-MN market, with the plurality of this provider's patient population coming from Minnehaha, SD. This provider's primary affiliated billing organization is VANCE THOMPSON VISION CLINIC PROF LLC (NPI: 1205193554; TIN: 454527794) and primary practice location at 57108-3162. Terveen is affiliated with the Avera Prairie View ACO (ACO ID: A4692), participating under the MSSP model.

Terveen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 533 traditional Medicare patients, billed 1,713 HCPCS/CPT codes, and received $360,765 in Medicare payments. The top billing code was 66991 (Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye). Part D data shows 281 prescription claims across 108 beneficiaries totaling $18,914 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). 2022 DME data shows 16 claims. Open Payments data shows 39 records totaling $61,456. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $25,790 to $360,765. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,678 and ending at $18,914. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	170	312	$25,790
2020	332	816	$157,090
2021	402	1,352	$302,708
2022	493	1,839	$380,964
2023	485	1,588	$345,406
2024	533	1,713	$360,765

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	14	28	$1,678
2016	53	161	$9,486
2017	95	384	$26,346
2018	120	335	$28,073
2019	150	460	$35,143
2020	70	198	$16,914
2021	64	188	$22,827
2022	43	117	$12,438
2023	59	154	$21,186
2024	108	281	$18,914

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	12	12	$639
2022	16	16	$830
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66991	Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye	29	49	$412
66984	Removal of cataract with insertion of prosthetic lens	313	586	$335
66821	Removal of recurring cataract in lens capsule using a laser	142	143	$329
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	36	36	$121
92136	Measurement of corneal curvature and depth of eye	321	615	$29

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	107	3,716	$4,209
Moxifloxacin	Moxifloxacin Hcl	69	1,469	$1,640
Diclofenac Sodium	Diclofenac Sodium	28	1,166	$324

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$1,239	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$60,218	Alcon Research LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel C. Terveen, M.D.?

Tedicare shows public-source Medicare data for Daniel C. Terveen, M.D. (NPI 1053791715), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel C. Terveen, M.D. have ACO affiliation data?

Daniel C. Terveen, M.D. is shown with ACO affiliation data for Avera Prairie View ACO (MSSP, ACO ID A4692).

What billing organization is linked to Daniel C. Terveen, M.D.?

Daniel C. Terveen, M.D. is linked to VANCE THOMPSON VISION CLINIC PROF LLC (billing NPI 1205193554) in the available physician profile data.

Does Daniel C. Terveen, M.D. have Open Payments data?

Daniel C. Terveen, M.D. has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.